KURA – kura oncology, inc. (US:NASDAQ)

News

Kura Oncology (KURA) had its "buy" rating reaffirmed by UBS Group AG.
Kura Oncology, Inc. (KURA) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
How The Kura Oncology (KURA) Story Is Shifting With Komzifti And New Street Targets [Yahoo! Finance]
Kura Oncology (KURA) had its price target lowered by Wedbush from $38.00 to $36.00. They now have an "outperform" rating on the stock.
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com